SCHEMBL6743784

SCHEMBL6743784

[CH2]Oc1cc(C#N)cc([N+](=O)[O-])c1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 4/20 0.67
XDH P47989 1/20 0.38
CYP19A1 P11511 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
MERTK Q12866 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.34
ALOX5 P09917 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
RAD51 Q06609 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6743785 0.83 VCAM1 (0.67) VCAM1XDHLMNAMAPTTSHR
SCHEMBL7090977 0.81 VCAM1 (0.91) VCAM1XDHCYP19A1GRIN2DGRIN3B
SCHEMBL1005421 0.81 VCAM1 (1.00) VCAM1XDHCYP19A1GRIN2DGRIN3B
SCHEMBL30508469 0.78 VCAM1 (0.59) VCAM1LMNAMAPTMEN1KMT2A
SCHEMBL28626079 0.78 VCAM1 (0.59) VCAM1XDHLMNAMAPTALOX5
SCHEMBL25409187 0.78 VCAM1 (0.59) VCAM1LMNAMAPTMEN1KMT2A
SCHEMBL6743457 0.77 TTR (0.36) VCAM1TSHRMEN1KMT2A
SCHEMBL6742047 0.77 VCAM1 (0.74) VCAM1XDHCYP19A1GRIN2DGRIN3B
SCHEMBL16953139 0.77 VCAM1 (0.74) VCAM1XDHCYP19A1GRIN2DGRIN3B
Acetonitrile SCHEMBL27788615 0.76 VCAM1 (0.88) VCAM1XDHCYP19A1GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689771-B2 TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, PERIODONTITIS, GINGIVITIS, CORNEAL ULCERATION, SOLID TUMOR GROWTH BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-02-10 US disclosed
US-6610731-B2 Antiinflammatory BRISTOL-MYERS SQUIBB COMPANY 2003-08-26 US disclosed
US-6403632-B1 CYCLIC AMIDE DERIVATIVE BRISTOL MYERS SQUIBB PHARMA CO (US) 2002-06-11 US disclosed
US-6376665-B1 ANTIARTHRITIC AGENTS, ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-04-23 US disclosed
EP-1165500-A1 AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES,TNF-ALPHA,AND AGGRECANASE Du Pont Pharmaceuticals Company (US) 2002-01-02 EP disclosed
WO-2000059874-A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 WO disclosed
US-6057336-A ANTIINFLAMMATORY AGENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2000-05-02 US disclosed